Thus, Ssa could decrease osteoclastogenesis to attenuate alveolar bone resorption in the rat model of periodontitis and attenuated bone loss by inhibiting the Nrf2/SCL7A11/GPX4 signaling pathway without osteoblast toxicity. Here, NFE2L2 is linked to periodontitis.